Priya Sehgal

Priya Sehgal

Gastroenterology | Hepatology

2211 Chapel Avenue West
Cherry Hill, NJ 08002

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Performance of Google NotebookLM for AI-assisted data extraction and consensus statement generation in a heterogenous systematic review on inflammatory bowel disease, obesity, and cardiometabolic comorbidities: A Methodological Report.

Performance of Google NotebookLM for AI-assisted data extraction and consensus statement generation in a heterogenous systematic review on inflammatory bowel disease, obesity, and cardiometabolic comorbidities: A Methodological Report.

Journal: medRxiv : the preprint server for health sciences

Published: July 03, 2026

Heading Toward a Different Future: The Microbiome, Dysbiosis, Microbial Translocation, and Beyond.

Heading Toward a Different Future: The Microbiome, Dysbiosis, Microbial Translocation, and Beyond.

Journal: The Journal of bone and joint surgery. American volume

Published: June 17, 2026

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method.

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method.

Journal: BMJ open

Published: May 26, 2026

Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.

Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.

Journal: Frontiers in gastroenterology (Lausanne, Switzerland)

Published: April 24, 2026

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriateness Method.

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriateness Method.

Journal: medRxiv : the preprint server for health sciences

Published: January 02, 2026

Clinical Considerations around the Development of Boys and Mental Health Outcomes in the Education System.

Clinical Considerations around the Development of Boys and Mental Health Outcomes in the Education System.

Journal: Child and adolescent psychiatric clinics of North America

Published: October 16, 2025

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.

Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis.

Journal: Journal of Crohn's & colitis

Published: October 10, 2025

Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis.

Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis.

Journal: Inflammatory bowel diseases

Published: August 22, 2025

Epidemiology of metabolic syndrome in patients with inflammatory bowel disease: a population-level cohort study from the United States.

Epidemiology of metabolic syndrome in patients with inflammatory bowel disease: a population-level cohort study from the United States.

Journal: Annals of gastroenterology

Published: August 05, 2025

Comparative effectiveness of low versus high dose upadacitinib as maintenance treatment in patients with ulcerative colitis: a real-world cohort study from the United States.

Comparative effectiveness of low versus high dose upadacitinib as maintenance treatment in patients with ulcerative colitis: a real-world cohort study from the United States.

Journal: Crohn's & colitis 360

Published: June 25, 2025

Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis-The Fat of the Matter: Authors' Reply.

Editorial: Obesity and Outcomes on Advanced Therapy in Ulcerative Colitis-The Fat of the Matter: Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: March 26, 2025

Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the U.S.

Obesity Is Associated With Worsened Outcomes in Patients With Ulcerative Colitis on Advanced Therapies: A Propensity Matched Cohort Study From the U.S.

Journal: Alimentary pharmacology & therapeutics

Published: November 03, 2024

Showing 1-12 of 28

Last Updated: 09/26/2026